Breast cancer, Secondary cancers
Results
Phase 2/3
This trial looked at a drug called cabazitaxel for breast cancer that had spread to another part of the body.
The trial was for women whose breast cancer cells had low or no amounts of HER2. This is called negative breast cancer.
Women could join between 2014 and 2020. The team published the results in 2022.
Recruitment start: 1 January 2015
Recruitment end: 20 March 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Amit Bahl
NIHR Clinical Research Network: Cancer
Sanofi Aventis
University Hospitals Bristol NHS Foundation Trust
Last reviewed: 17 Mar 2026
CRUK internal database number: 12650
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
